Zhejiang Huahai Pharmaceutical(600521.SH): Telmisartan tablets obtain medicinal registration certificate

Zhejiang Huahai Pharmaceutical (600521.SH) announced that the company recently received the Drug Registration Certificate for Telmisartan Tablets issued by the National Medical Products Administration (referred to as the "NMPA"). Telmisartan tablets are used to treat hypertension and reduce cardiovascular risk.